Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC

Guanming Jiao1, Qi Huang2, Muren Hu2

  • 1Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.

Insights

MicroRNA-4261 (miR-4261) promotes colorectal cancer growth by suppressing the tumor suppressor gene mutated in colorectal cancer (MCC). Inhibiting miR-4261 offers a potential therapeutic strategy for colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The mutated in colorectal cancer (MCC) gene is a critical tumor suppressor in colorectal cancer.
  • Limited research exists on microRNAs (miRNAs) directly targeting MCC in colorectal cancer.

Purpose of the Study:

  • To identify microRNAs targeting MCC in colorectal cancer.
  • To investigate the functional role of miR-4261 in colorectal cancer progression.
  • To explore the therapeutic potential of targeting miR-4261.

Main Methods:

  • Utilized miRNA target prediction algorithms and microarray data.
  • Analyzed miR-4261 expression in patient specimens and cell lines (HCT116, HT29).
  • Performed luciferase reporter assays, Western blot, and in vivo xenograft studies.

Main Results:

  • miR-4261 was predicted by multiple databases to target MCC and was overexpressed in colorectal cancer.
  • Overexpression of miR-4261 enhanced cell proliferation, cell cycle progression, and migration.
  • Inhibition of miR-4261 reversed these effects; MCC was confirmed as a direct target.
  • Therapeutic inhibition of miR-4261 reduced tumor growth in xenografts.

Conclusions:

  • This study identifies miR-4261 as a novel oncogenic miRNA in colorectal cancer.
  • miR-4261 promotes colorectal cancer progression by targeting the MCC tumor suppressor gene.
  • Targeting miR-4261 presents a promising therapeutic avenue for colorectal cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K